Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?

Wout W A van den Broek*, Jurriën M Ten Berg

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)4599-4600
Number of pages2
JournalEuropean Heart Journal
Issue number43
Early online date9 Jun 2022
Publication statusPublished - 14 Nov 2022

Cite this